{"title":"Damages for Breach of a Forum Selection Clause","authors":"Tanya J. Monestier","doi":"10.1111/ablj.12183","DOIUrl":"https://doi.org/10.1111/ablj.12183","url":null,"abstract":"<p>When a party breaches a forum selection clause, a court will normally dismiss the action, therefore forcing the breaching party to re-file in the appropriate forum, or the court will transfer the proceedings to the chosen court. Either way, the nonbreaching party appears to have gotten what he wanted: litigation to proceed before the designated court. However, to get there, the nonbreaching party had to outlay significant expenditures in the form of attorneys' fees. Are these attorneys' fees recoverable as damages? Should they be?</p><p>This Article argues that attorneys' fees associated with remedying a breach of a forum selection clause should be recoverable as damages flowing from the breach. Without the prospect of having to pay damages, the breaching party would be permitted to breach a forum selection clause with impunity. In other words, there is no downside to breaching a forum selection clause. Best case scenario, the non-designated court retains jurisdiction; worst case scenario, the breaching party is “sent” to the contractually-designated forum.</p><p>Awarding attorneys' fees for breach of a forum selection clause does not run afoul of the American Rule, which requires each side to bear their own costs and attorneys' fees. This is because attorneys' fees for breach of a forum selection clause are a measure of direct damages—and not consequential damages—and therefore do not implicate the American Rule.</p>","PeriodicalId":54186,"journal":{"name":"American Business Law Journal","volume":"58 2","pages":"271-325"},"PeriodicalIF":1.2,"publicationDate":"2021-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/ablj.12183","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71976604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Does Conjoint Analysis Reliably Value Patents?","authors":"Bernard Chao, Sydney Donovan","doi":"10.1111/ablj.12182","DOIUrl":"https://doi.org/10.1111/ablj.12182","url":null,"abstract":"<p>Modern technology products are often covered by thousands of patents. Yet awards for a single component have averaged a surprisingly high 9.98% of the infringing product's price. To curb such disproportionate awards, the law insists that damages reflect the contribution made by the patent. But determining how to apportion damages in this way has proved to be elusive. One emerging technique that appears to offer rigor is conjoint analysis, a type of survey borrowed from the marketing world. This article explores the validity of the conjoint analysis technique by running two conjoint analysis surveys. Unfortunately, we found serious problems. First, the results of our surveys yielded irrationally high numbers. Most survey features suffered from bizarrely high valuations. Second, we demonstrate how experts can manipulate the results by selecting among a number of different ostensibly reasonable statistical choices and picking the one that yields the most desirable outcome. Based on these findings, we provide several recommendations. First, we argue that courts should not allow evidence of conjoint analysis to show the monetary value of specific features. However, we recognize that there is support for using conjoint analysis to provide relative valuations (i.e., feature A is worth significantly more than feature B). To the extent that courts permit this use, we suggest ways to ensure that experts employ the best science available. These recommendations include assuring that experts accurately depict variability in their results and requiring experts to “preregister” the approach they intend to use with the court.</p>","PeriodicalId":54186,"journal":{"name":"American Business Law Journal","volume":"58 2","pages":"225-269"},"PeriodicalIF":1.2,"publicationDate":"2021-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/ablj.12182","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71976603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Protecting Third Parties in Contracts","authors":"Kishanthi Parella","doi":"10.1111/ablj.12184","DOIUrl":"https://doi.org/10.1111/ablj.12184","url":null,"abstract":"<p>Corporations routinely impose externalities on a broad range of non-shareholders, as illustrated by several unsuccessful lawsuits against corporations involving forced labor, human trafficking, child labor, and environmental harms in global supply chains. Lack of legal accountability subsequently translates into low legal risk for corporate misconduct, which reduces the likelihood of prevention. Corporate misconduct toward non-shareholders arises from a fundamental inconsistency within contract law regarding the status of third parties: On the one hand, we know that it takes a community to contract. Contracting parties often rely on multiple third parties—not signatories to the contract—to play important roles in facilitating exchange, such as reducing market transaction costs, improving information flows, and decreasing the risk of opportunism. On the other hand, we deny this community protection from the externalities that contracting parties impose on them. This article examines a corporation's duties to others in its role as a contracting party. Normatively, this article proposes an alternative view of contracts as an ecosystem with three attendant principles that result from this view: (a) third-party protections from negative externalities, (b) contract design obligations of contracting parties, and (c) recourse to legal remedies for third parties. On a policy level, this article proposes the following duty to contract in order to translate theory into practice: Contracting parties are required to take into account negative externalities to third parties when the contracting parties could reasonably foresee that performance of the contract would create a risk of physical harm to these third parties.</p>","PeriodicalId":54186,"journal":{"name":"American Business Law Journal","volume":"58 2","pages":"327-386"},"PeriodicalIF":1.2,"publicationDate":"2021-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/ablj.12184","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71976602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Aligning National Bank Priorities with the Public Interest: National Benefit Banks and a New Stakeholder Approach","authors":"Lindsay Sain Jones","doi":"10.1111/ablj.12178","DOIUrl":"https://doi.org/10.1111/ablj.12178","url":null,"abstract":"<p>Banks have particular characteristics that set them apart from other business entities, including being more highly leveraged, benefiting from government safety nets, and generating massive negative externalities when they fail. These attributes mean that in addition to shareholder interests, bank directors should be allowed to carefully consider the interests of nonshareholders, such as creditors, taxpayers, and the overall economy, when making decisions. While directors of banks in states that have enacted constituency statutes may be allowed to consider nonshareholder interests, no federal act expressly allows directors of federally chartered banks to consider such interests. Moreover, to date, thirty-seven states have enacted legislation to allow for the formation of public benefit corporations that require directors to consider the interests of nonshareholders. No federal law provides a clear path for federally chartered banks to do this. This article proposes dual federal legislation that would (1) enable directors of all federally chartered banks to expressly consider nonshareholder constituents when making decisions and (2) allow for the formation of national benefit banks that would require directors to consider nonshareholder interests in their decision-making.</p>","PeriodicalId":54186,"journal":{"name":"American Business Law Journal","volume":"58 1","pages":"5-61"},"PeriodicalIF":1.2,"publicationDate":"2021-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/ablj.12178","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71989575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Legal Entrepreneurship and the Strategic Virtues of Legal Uncertainty","authors":"","doi":"10.1111/ablj.12177","DOIUrl":"https://doi.org/10.1111/ablj.12177","url":null,"abstract":"<p>In Evans et al1, Figure 4 was omitted from the published article. The Figure 4 image can be found below.</p><p>For the reader's convenience, Figure 4 image is first referenced at page 641 of the article. We apologize for this error.</p>","PeriodicalId":54186,"journal":{"name":"American Business Law Journal","volume":"57 4","pages":"955"},"PeriodicalIF":1.2,"publicationDate":"2021-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/ablj.12177","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71984954","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Up in Smoke: International Treaty Obligations and Marijuana Reform in the United States","authors":"Kevin J. Fandl","doi":"10.1111/ablj.12181","DOIUrl":"10.1111/ablj.12181","url":null,"abstract":"<p><i>As the number of U.S. states that seek to loosen restrictions on marijuana rapidly increases, a heated debate over state and federal regulation has ignited. But an important component of that debate has been largely absent—are these state efforts placing the United States in violation of its international treaty obligations? This article attempts to answer this question by tracing the history of marijuana regulation both in the United States and abroad and outlining the foundations for domestic legislation. It argues that the experiments happening among a number of states and countries to liberalize marijuana laws are bearing fruit and should be tied to a broader reform agenda of the same international narcotics treaties that the United States sought decades ago.</i></p>","PeriodicalId":54186,"journal":{"name":"American Business Law Journal","volume":"58 1","pages":"163-220"},"PeriodicalIF":1.2,"publicationDate":"2021-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/ablj.12181","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42217293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Symposium, Cannabis—Legal, Ethical, and Compliance Issues: Introduction","authors":"Gideon Mark, Laurie A. Lucas","doi":"10.1111/ablj.12176","DOIUrl":"10.1111/ablj.12176","url":null,"abstract":"<p>This introduction reviews six articles presented at the 2020 symposium, “Legal, Ethical, and Compliance Issues in Emerging Markets: Cannabis in the States.” Scholars from across the United States and Canada presented research using the lens of law and strategy, ethics, and compliance to focus on the U.S. cannabis industry. The articles are discussed within the framework of institutional voids common to emerging markets, which may include a lack of a fully developed regulatory system and issues related to financial markets. These institutional problems create complexity for consumers, producers, municipalities, and state governments in this industry, and make success for this market segment more challenging. The introduction contributes to the discussion by reviewing securities litigation involving the cannabis industry generally and specifically in light of some of the issues identified by authors in the special issue.</p>","PeriodicalId":54186,"journal":{"name":"American Business Law Journal","volume":"57 4","pages":"651-676"},"PeriodicalIF":1.2,"publicationDate":"2021-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/ablj.12176","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41542086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cannabis Regulatory Confusion and Its Impact on Consumer Adoption","authors":"Stephanie Geiger-Oneto, Robert Sprague","doi":"10.1111/ablj.12171","DOIUrl":"10.1111/ablj.12171","url":null,"abstract":"<p><i>The regulation of cannabis in the United States is inconsistent and contradictory, to put it mildly. While marijuana remains classified as a Schedule I substance under the federal Controlled Substance Act—in the same category as heroin and morphine, with accompanying criminal penalties up to and including life imprisonment for its production, distribution, and possession—as of the end of 2020, eleven states and the District of Columbia had legalized recreational marijuana use and thirty-six states and the District of Columbia had decriminalized the use of marijuana for medical purposes. Despite the trend toward legalization, however, marijuana is a stigmatized product. Stigmatized products are those toward which a significant portion of consumers hold negative attitudes and beliefs, whereas the concept of legitimacy is defined as a generalized perception or assumption that the actions of an entity are desirable, proper, or appropriate within some socially constructed system of norms, values, beliefs, and definitions. This article addresses how current legislation and regulations influence consumer perceptions of a product category, and how conflicting regulations (or the lack of regulations) influence the adoption of a stigmatized product such as cannabis (i.e., marijuana and cannabidiol products)</i></p>","PeriodicalId":54186,"journal":{"name":"American Business Law Journal","volume":"57 4","pages":"735-772"},"PeriodicalIF":1.2,"publicationDate":"2021-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/ablj.12171","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42689800","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Aubree L. Walton, Kaimee Kellis, William E. Tankersley, Rikinkumar S. Patel
{"title":"Cultivating Evidence-Based Pathways for Cannabis Product Development: Implications for Consumer Protection†","authors":"Aubree L. Walton, Kaimee Kellis, William E. Tankersley, Rikinkumar S. Patel","doi":"10.1111/ablj.12173","DOIUrl":"10.1111/ablj.12173","url":null,"abstract":"<p>Disparities between federal and state cannabis regulation, coupled with protracted federal enforcement, have facilitated the proliferation of a multi–billion dollar cannabis industry that generally evades compliance with federal consumer protection laws. The Federal Food, Drug and Cosmetic Act (FDCA) established regulatory pathways for the lawful development of products such as food, drugs, and dietary supplements. The FDCA uses a science-based approach to protect consumers from harmful products, but early inconsistencies between state and federal cannabis regulation prevented and/or discouraged the cannabis industry from complying with FDCA requirements. Cannabis products are promoted as safe and attributed with providing effective therapeutic treatment for numerous medical conditions, yet the claims often lack the rigorous evidence-based support typically expected by regulators and the medical community. The Food and Drug Administration (FDA) has announced its expectation that cannabidiol (CBD) products comply with the FDCA and follow a science-based approach to product development. The FDA is addressing violations involving unsubstantiated CBD health claims and is working to clarify the future regulatory pathway for CBD products. Meanwhile, the state-approved cannabis market continues to operate, selling numerous products that have circumvented the FDCA consumer protections. This article examines the need for strengthening consumer protections in the cannabis market. We use evidence-based medicine as a model to address the importance of science-based product development and to contextualize a science-based comparison of regulatory pathways for cannabis drugs, food, and dietary supplements.</p>","PeriodicalId":54186,"journal":{"name":"American Business Law Journal","volume":"57 4","pages":"773-825"},"PeriodicalIF":1.2,"publicationDate":"2021-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/ablj.12173","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46039969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Taxing Cannabis on the Reservation","authors":"Mark J. Cowan","doi":"10.1111/ablj.12174","DOIUrl":"https://doi.org/10.1111/ablj.12174","url":null,"abstract":"<p>American Indian tribes that enter the cannabis industry confront a multisovereign tax system that lacks certainty and horizontal equity. The complex interaction of state legalization and taxation of cannabis, federal tax law, the status of tribes as both governments and business enterprises, and the legal and tax landscape in Indian country can give tribes tax advantages and disadvantages compared to off-reservation cannabis dispensaries. This article analyzes these tax issues, examines them in the context of prior challenges posed by Indian gaming, and suggests reforms that address the tax inequities that can result from cannabis sales on Indian reservations.</p>","PeriodicalId":54186,"journal":{"name":"American Business Law Journal","volume":"57 4","pages":"867-911"},"PeriodicalIF":1.2,"publicationDate":"2021-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1111/ablj.12174","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71983722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}